Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 2, 2013

Sofie Bio Seeks to Speed PET Probe Synthesis with SBIR Grant

  • The NIH has awarded Sofie Biosciences a roughly $1.8 million SBIR grant to support the development of digital chip technology for the synthesis of PET probes for neurobiology applications. The three-year grant will be administered by the National Institute of Mental Health (NIMH).

    According to the company, by developing a point-of-care radiosynthesizer that integrates the many unit operations for synthesis, purification, and quality control into a benchtop, affordable device, access to the vast library (3,000+) of PET probes will be facilitated. Currently a major roadblock to using PET is the expensive equipment and specialized personnel required.

    The SBIR award will augment the company’s internal R&D investment, allowing it to accelerate the commercialization of a microfluidic-based radiosynthesizer for synthesizing PET probes on-demand for brain imaging and other applications.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »